Метилирование генов микроРНК miR-129-2, miR-9-1, изменение их экспрессии и активация генов потенциальных мишеней этих микроРНК при раке почки
И. В. Пронина(Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences), В. И. Логинов(Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences), Е. В. Береснева(Genetika), Т.П. Казубская(Ministry of Health), А. М. Бурденный(Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences), М. В. Фридман(New York University), Е.А. Климов(Lomonosov Moscow State University), Э. А. Брага(Research Centre for Medical Genetics), А. В. Карпухин, В. Д. Ермилова(Russian Cancer Research Center NN Blokhin)
Unknown
January 1, 2017
Cited by 0
Related Papers
In vivo measurement of afferent activity with axon-specific calcium imaging
|Nature Neuroscience|2018|249
LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms
|International Journal of Molecular Sciences|2020|230
Landscape of allele-specific transcription factor binding in the human genome
|Nature Communications|2021|204
Molecular mechanisms and microRNAs in osteosarcoma pathogenesis
|Biochemistry (Moscow)|2016|121
Long Noncoding RNA GAS5 in Breast Cancer: Epigenetic Mechanisms and Biological Functions
|International Journal of Molecular Sciences|2021|94